Arbutus Biopharma
ABUS
ABUS
50 hedge funds and large institutions have $174M invested in Arbutus Biopharma in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
50
Holding in Top 10
–
Calls
$7.7M
Puts
$3.4M
Top Buyers
| 1 | +$17M | |
| 2 | +$9.66M | |
| 3 | +$8.96M | |
| 4 |
SCM
Sigma Capital Management
Stamford,
Connecticut
|
+$6.45M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$6.33M |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$2.77M | |
| 3 | -$488K | |
| 4 |
B
Bailard
Foster City,
California
|
-$436K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$341K |